carbapenems has been researched along with Infection in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 4 (50.00) | 24.3611 |
| 2020's | 2 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gatti, M; Giannella, M; Scudeller, L; Viale, P | 1 |
| Chen, C; Yang, K | 1 |
| Kaier, K; Mutters, NT; Wolkewitz, M | 1 |
| Chong, CY; Krishnaswamy, G; Ong, YL; Seah, XF; Tan, NW; Tan, SW; Thoon, KC | 1 |
| Clarke, MJ; Edwards, SJ; Welton, NJ; Wordsworth, S | 1 |
| Kuper, KM; Septimus, EJ | 1 |
| Cho, JY; Han, HK; Jang, IJ; Kim, TE; Lim, KS; Park, MK; Shin, KH; Shin, SG; Yi, SJ; Yu, KS | 1 |
| Aypak, C; Bayram, I; Bayram, Y; Parlak, M | 1 |
1 review(s) available for carbapenems and Infection
| Article | Year |
|---|---|
Clinical challenges in addressing resistance to antimicrobial drugs in the twenty-first century.
Topics: Anti-Infective Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Drug Resistance, Microbial; Drug Resistance, Multiple; Humans; Infection Control; Infections; Methicillin-Resistant Staphylococcus aureus | 2009 |
7 other study(ies) available for carbapenems and Infection
| Article | Year |
|---|---|
Adaptive trials of new antimicrobials for infections with carbapenem-resistant, Gram-negative bacteria.
Topics: Anti-Bacterial Agents; Carbapenems; Drug Resistance, Bacterial; Gram-Negative Bacteria; Humans; Infections; Marketing | 2020 |
Ruthenium complexes as prospective inhibitors of metallo-β-lactamases to reverse carbapenem resistance.
Topics: Amino Acid Sequence; Animals; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; Binding Sites; Carbapenems; Coordination Complexes; Disease Models, Animal; Drug Development; Drug Resistance, Microbial; Escherichia coli; Infections; Meropenem; Mice; Microbial Sensitivity Tests; Prospective Studies; Protein Binding; Protein Conformation; Ruthenium; Structure-Activity Relationship; Zinc | 2020 |
Measuring the Financial Burden of Resistance: What Should Be Compared?
Topics: Carbapenems; Cost of Illness; Health Expenditures; Humans; Infections; Klebsiella pneumoniae | 2019 |
Impact of an antimicrobial stewardship program on the use of carbapenems in a tertiary women's and children's hospital, Singapore.
Topics: Anti-Infective Agents; Carbapenems; Child; Cost Savings; Drug Administration Schedule; Drug Costs; Electronic Prescribing; Female; Health Plan Implementation; Humans; Inappropriate Prescribing; Infection Control; Infections; Length of Stay; Male; Middle Aged; Patient Readmission; Practice Guidelines as Topic; Practice Patterns, Physicians'; Prospective Studies; Singapore; Tertiary Care Centers | 2014 |
Carbapenems versus other beta-lactams in the treatment of hospitalised patients with infection: a mixed treatment comparison.
Topics: beta-Lactams; Carbapenems; Hospitalization; Humans; Infections; Inpatients; Randomized Controlled Trials as Topic | 2009 |
Reduced valproic acid serum concentrations due to drug interactions with carbapenem antibiotics: overview of 6 cases.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Carbapenems; Drug Interactions; Drug Monitoring; Female; Half-Life; Humans; Infections; Male; Middle Aged; Retrospective Studies; Seizures; Valproic Acid; Young Adult | 2012 |
Three-year review of bacteriological profile and antibiogram of burn wound isolates in Van, Turkey.
Topics: Adult; Amikacin; Burns; Carbapenems; Child; Child, Preschool; Drug Resistance, Multiple, Bacterial; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Infections; Male; Retrospective Studies; Turkey | 2013 |